IBOV 173,325.65 ▼ 0.03% IPSA 10,954.04 ▲ 0.52% IPC MEX 66,709.60 ▲ 0.88% MERVAL 3,281,979 — 0.00% COLCAP 2,301.34 ▲ 0.13% BVL PERÚ 56,620.35 — — USD/BRL5.07▼ 0.04% USD/MXN17.41▲ 0.01% USD/CLP934.18▼ 0.16% USD/COP3,220▼ 1.11% USD/PEN3.40▲ 0.07% USD/ARS1,478▼ 0.27% USD/UYU40.11▲ 1.23% USD/PYG6,045▲ 1.76% USD/BOB10.80▲ 2.69% USD/DOP58.02▼ 0.31% USD/CRC446.12▲ 1.15% USD/GTQ7.62▲ 2.33% USD/HNL26.74▲ 1.61% USD/NIO36.62▲ 0.72% USD/VES735.39▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.79▲ 0.73% USD/TTD6.73▲ 1.11% EUR/BRL5.78▼ 0.62% BRENT 84.46 ▼ 7.20% WTI 87.37 ▲ 2.90% IRON ORE 161.91 — — COPPER 6.52 ▲ 0.10% GOLD 4,121 ▲ 1.23% SILVER 59.64 ▲ 1.36% SOY 1,225 ▲ 0.47% CORN 479.50 ▲ 5.91% WHEAT 687.00 ▲ 1.33% COFFEE 320.70 ▼ 3.39% SUGAR 14.78 ▼ 0.67% ORANGE JUICE 142.30 ▼ 3.46% COTTON 80.15 ▲ 1.51% COCOA 5,462 ▼ 2.59% BEEF 223.05 ▼ 1.53% CATTLE 344.88 ▼ 2.02% LITHIUM 69.08 ▲ 3.23% PETR4 41.66 ▲ 1.24% VALE3 72.37 ▲ 0.61% ITUB4 42.53 ▲ 0.54% BBDC4 18.55 ▲ 0.76% ABEV3 15.80 ▲ 0.06% BBAS3 20.88 ▲ 3.52% B3SA3 15.17 ▼ 0.59% WEGE3 42.47 ▼ 1.53% PRIO3 58.18 ▲ 0.85% SUZB3 41.63 ▼ 0.62% RENT3 36.55 ▼ 2.51% AZZA3 17.48 ▼ 3.80% CSAN3 3.78 ▼ 1.05% RAIZ4 0.27 — 0.00% PCAR3 2.73 ▲ 5.00% GMAT3 3.83 ▼ 0.52% PSSA3 53.48 ▼ 1.33% CVCB3 1.12 ▲ 3.70% POSI3 3.68 ▼ 0.54% SLCE3 13.75 ▲ 1.33% NATU3 8.71 ▲ 0.93% BRKM5 5.71 ▼ 3.87% RANI3 7.89 ▼ 1.25% CSNA3 5.06 ▼ 0.20% CMIN3 5.58 ▲ 3.53% USIM5 8.46 ▲ 3.68% GGBR4 23.49 ▼ 0.55% ENEV3 25.42 ▼ 0.90% CPFE3 46.40 ▲ 0.17% CMIG4 11.02 — 0.00% EQTL3 38.83 ▼ 1.17% LREN3 13.27 ▼ 0.30% VIVT3 35.80 ▲ 0.36% RAIL3 13.24 ▼ 2.43% KLABIN 17.59 ▲ 0.63% RAIA DROGASIL 18.13 ▼ 3.00% RDOR3 33.92 ▼ 4.32% HAPV3 11.24 ▼ 2.68% FLRY3 16.55 ▼ 0.06% SMTO3 15.58 ▲ 1.10% UGPA3 31.82 ▲ 0.38% VBBR3 33.95 ▼ 0.47% BBSE3 41.55 ▲ 1.22% BPAC11 55.37 ▼ 0.84% CURY3 29.95 ▼ 0.80% AERI3 2.04 ▼ 1.45% VIVARA 21.41 ▼ 2.50% COMPASS 24.44 ▼ 0.65% VAMOS 3.09 — 0.00% SANB11 27.21 ▲ 0.74% ASAI3 8.25 ▲ 1.35% SBSP3 28.60 ▼ 1.31% WALMEX 49.15 ▼ 0.47% GMEXICO 209.54 ▲ 4.34% FEMSA 226.99 ▲ 0.01% CEMEX 22.07 ▲ 0.87% GFNORTE 185.80 ▲ 3.22% BIMBO 59.39 ▼ 0.18% TELEVISA 9.70 ▼ 0.10% AMX 22.76 ▲ 0.09% GAP 378.85 ▲ 0.17% ASUR 274.96 ▲ 0.22% OMA 225.89 ▼ 0.24% KOF 181.05 ▲ 0.13% GRUMA 282.60 ▼ 1.74% KIMBER 38.40 ▲ 0.03% SQM-B 64,540 ▲ 2.25% COPEC 6,450 ▲ 4.03% BSANTANDER 79.01 ▲ 3.84% FALABELLA 5,919 ▲ 0.75% ENELAM 84.53 ▲ 0.50% CENCOSUD 2,028 ▲ 1.66% CMPC 1,084 ▲ 1.67% BANCO CHILE 190.01 ▲ 1.89% LATAM AIR 24.20 ▼ 0.86% YPF 80,625 ▲ 1.80% GGAL 7,965 ▲ 1.53% PAMPA 5,475 ▲ 3.89% TXAR 679.00 ▲ 1.27% ALUAR 973.00 ▲ 1.41% TGS 9,710 ▲ 2.21% CEPU 2,340 ▲ 2.23% MIRGOR 16,775 ▼ 2.04% COME 42.87 ▼ 0.19% LOMA NEGRA 3,605 ▲ 0.91% BYMA 292.25 ▼ 0.51% TELECOM ARG 4,255 ▲ 2.65% ECOPETROL 16.53 ▲ 3.09% BANCOLOMBIA 83.64 ▲ 3.49% GRUPO AVAL 5.09 ▲ 2.83% CREDICORP 391.10 ▲ 1.10% SOUTHERN COPPER 188.01 ▲ 7.39% BUENAVENTURA 31.25 ▲ 3.96% MERCADOLIBRE 1,823 ▼ 0.53% NUBANK 14.39 ▲ 2.86% XP 16.85 ▲ 0.30% PAGSEGURO 9.58 ▲ 3.12% STONE 11.26 ▲ 1.21% GLOBANT 32.10 ▼ 0.59% TECNOGLASS 45.15 ▼ 2.08% GAP AIRPORT 217.68 ▲ 0.26% ASUR 274.96 ▲ 0.22% OMA AIRPORT 104.23 ▲ 0.21% AMX ADR 26.09 ▼ 0.04% FEMSA ADR 130.35 ▲ 0.26% CEMEX ADR 12.70 ▲ 1.68% PETROBRAS ADR 18.54 ▲ 1.92% VALE ADR 14.25 ▲ 1.06% ITAU ADR 8.40 ▲ 0.96% SANTANDER BR 5.40 ▲ 0.56% AMBEV ADR 3.11 ▲ 0.97% CSN 1.01 ▼ 0.50% GERDAU 4.64 ▼ 0.85% LATAM ADR 51.58 ▼ 0.31% BTC 66,032 ▼ 0.71% ETH 1,931 ▲ 0.14% SOL 77.63 ▼ 0.61% XRP 1.14 ▼ 0.33% BNB 571.09 ▼ 0.44% ADA 0.17 ▲ 0.09% DOGE 0.07 ▼ 0.75% AVAX 6.52 ▼ 0.63% LINK 8.67 ▲ 0.21% DOT 0.84 ▼ 0.57% LTC 46.58 ▼ 0.50% BCH 222.18 ▼ 0.68% TRX 0.33 ▲ 0.19% XLM 0.19 ▼ 1.07% HBAR 0.07 ▲ 2.64% NEAR 1.89 ▼ 2.43% ATOM 1.46 ▼ 1.35% AAVE 96.12 ▲ 0.57% SELIC 14.25% EMBRAER 82.65 ▼ 0.77% EMBRAER ADR 65.47 ▼ 0.70% JBS 11.95 ▼ 0.67% JBS BDR 60.22 ▼ 0.94% MBRF3 15.11 ▲ 4.06% MBRFY 2.95 ▲ 1.37% INTER 5.58 ▼ 0.71% EGX 53,923 ▼ 0.12% USD/ZAR16.46▼ 0.05% USD/NGN 1,376 — 0.00% NIKKEI 66,116 ▼ 0.18% CSI300 4,717 ▼ 0.46% HSI 24,893 ▼ 0.95% NIFTY 23,996 ▼ 0.79% KOSPI 6,798 ▲ 0.74% JCI 6,334 ▼ 0.09% USD/JPY163.06▼ 0.07% USD/CNY6.76▼ 0.08% DAX 25,147 ▲ 0.54% CAC 8,439 ▲ 0.90% FTSE 10,702 ▲ 1.10% MIB 52,762 ▲ 0.91% IBEX 19,576 ▲ 1.01% STOXX 646.65 ▲ 0.54% EUR/USD1.14▲ 0.10% GBP/USD1.34▼ 0.48% SPX 7,509 ▲ 0.89% DJI 52,225 ▲ 0.74% NDX 29,155 ▲ 1.93% RUT 2,987 ▲ 1.53% TSX 35,369 ▲ 1.17% VIX 17.45 ▲ 2.35% USD/CAD1.41▼ 0.06% US10Y 4.6280 ▲ 0.65% IBOV 173,325.65 ▼ 0.03% IPSA 10,954.04 ▲ 0.52% IPC MEX 66,709.60 ▲ 0.88% MERVAL 3,281,979 — 0.00% COLCAP 2,301.34 ▲ 0.13% BVL PERÚ 56,620.35 — — USD/BRL 5.07 ▼ 0.04% USD/MXN 17.41 ▲ 0.01% USD/CLP 934.18 ▼ 0.16% USD/COP 3,220 ▼ 1.11% USD/PEN 3.40 ▲ 0.07% USD/ARS 1,478 ▼ 0.27% USD/UYU 40.11 ▲ 1.23% USD/PYG 6,045 ▲ 1.76% USD/BOB 10.80 ▲ 2.69% USD/DOP 58.02 ▼ 0.31% USD/CRC 446.12 ▲ 1.15% USD/GTQ 7.62 ▲ 2.33% USD/HNL 26.74 ▲ 1.61% USD/NIO 36.62 ▲ 0.72% USD/VES 735.39 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.79 ▲ 0.55% USD/TTD 6.73 ▲ 1.02% EUR/BRL 5.78 ▼ 0.62% BRENT 84.46 ▼ 7.20% WTI 87.37 ▲ 2.90% IRON ORE 161.91 — — COPPER 6.52 ▲ 0.10% GOLD 4,121 ▲ 1.23% SILVER 59.64 ▲ 1.36% SOY 1,225 ▲ 0.47% CORN 479.50 ▲ 5.91% WHEAT 687.00 ▲ 1.33% COFFEE 320.70 ▼ 3.39% SUGAR 14.78 ▼ 0.67% ORANGE JUICE 142.30 ▼ 3.46% COTTON 80.15 ▲ 1.51% COCOA 5,462 ▼ 2.59% BEEF 223.05 ▼ 1.53% CATTLE 344.88 ▼ 2.02% LITHIUM 69.08 ▲ 3.23% PETR4 41.66 ▲ 1.24% VALE3 72.37 ▲ 0.61% ITUB4 42.53 ▲ 0.54% BBDC4 18.55 ▲ 0.76% ABEV3 15.80 ▲ 0.06% BBAS3 20.88 ▲ 3.52% B3SA3 15.17 ▼ 0.59% WEGE3 42.47 ▼ 1.53% PRIO3 58.18 ▲ 0.85% SUZB3 41.63 ▼ 0.62% RENT3 36.55 ▼ 2.51% AZZA3 17.48 ▼ 3.80% CSAN3 3.78 ▼ 1.05% RAIZ4 0.27 — 0.00% PCAR3 2.73 ▲ 5.00% GMAT3 3.83 ▼ 0.52% PSSA3 53.48 ▼ 1.33% CVCB3 1.12 ▲ 3.70% POSI3 3.68 ▼ 0.54% SLCE3 13.75 ▲ 1.33% NATU3 8.71 ▲ 0.93% BRKM5 5.71 ▼ 3.87% RANI3 7.89 ▼ 1.25% CSNA3 5.06 ▼ 0.20% CMIN3 5.58 ▲ 3.53% USIM5 8.46 ▲ 3.68% GGBR4 23.49 ▼ 0.55% ENEV3 25.42 ▼ 0.90% CPFE3 46.40 ▲ 0.17% CMIG4 11.02 — 0.00% EQTL3 38.83 ▼ 1.17% LREN3 13.27 ▼ 0.30% VIVT3 35.80 ▲ 0.36% RAIL3 13.24 ▼ 2.43% KLABIN 17.59 ▲ 0.63% RAIA DROGASIL 18.13 ▼ 3.00% RDOR3 33.92 ▼ 4.32% HAPV3 11.24 ▼ 2.68% FLRY3 16.55 ▼ 0.06% SMTO3 15.58 ▲ 1.10% UGPA3 31.82 ▲ 0.38% VBBR3 33.95 ▼ 0.47% BBSE3 41.55 ▲ 1.22% BPAC11 55.37 ▼ 0.84% CURY3 29.95 ▼ 0.80% AERI3 2.04 ▼ 1.45% VIVARA 21.41 ▼ 2.50% COMPASS 24.44 ▼ 0.65% VAMOS 3.09 — 0.00% SANB11 27.21 ▲ 0.74% ASAI3 8.25 ▲ 1.35% SBSP3 28.60 ▼ 1.31% WALMEX 49.15 ▼ 0.47% GMEXICO 209.54 ▲ 4.34% FEMSA 226.99 ▲ 0.01% CEMEX 22.07 ▲ 0.87% GFNORTE 185.80 ▲ 3.22% BIMBO 59.39 ▼ 0.18% TELEVISA 9.70 ▼ 0.10% AMX 22.76 ▲ 0.09% GAP 378.85 ▲ 0.17% ASUR 274.96 ▲ 0.22% OMA 225.89 ▼ 0.24% KOF 181.05 ▲ 0.13% GRUMA 282.60 ▼ 1.74% KIMBER 38.40 ▲ 0.03% SQM-B 64,540 ▲ 2.25% COPEC 6,450 ▲ 4.03% BSANTANDER 79.01 ▲ 3.84% FALABELLA 5,919 ▲ 0.75% ENELAM 84.53 ▲ 0.50% CENCOSUD 2,028 ▲ 1.66% CMPC 1,084 ▲ 1.67% BANCO CHILE 190.01 ▲ 1.89% LATAM AIR 24.20 ▼ 0.86% YPF 80,625 ▲ 1.80% GGAL 7,965 ▲ 1.53% PAMPA 5,475 ▲ 3.89% TXAR 679.00 ▲ 1.27% ALUAR 973.00 ▲ 1.41% TGS 9,710 ▲ 2.21% CEPU 2,340 ▲ 2.23% MIRGOR 16,775 ▼ 2.04% COME 42.87 ▼ 0.19% LOMA NEGRA 3,605 ▲ 0.91% BYMA 292.25 ▼ 0.51% TELECOM ARG 4,255 ▲ 2.65% ECOPETROL 16.53 ▲ 3.09% BANCOLOMBIA 83.64 ▲ 3.49% GRUPO AVAL 5.09 ▲ 2.83% CREDICORP 391.10 ▲ 1.10% SOUTHERN COPPER 188.01 ▲ 7.39% BUENAVENTURA 31.25 ▲ 3.96% MERCADOLIBRE 1,823 ▼ 0.53% NUBANK 14.39 ▲ 2.86% XP 16.85 ▲ 0.30% PAGSEGURO 9.58 ▲ 3.12% STONE 11.26 ▲ 1.21% GLOBANT 32.10 ▼ 0.59% TECNOGLASS 45.15 ▼ 2.08% GAP AIRPORT 217.68 ▲ 0.26% ASUR 274.96 ▲ 0.22% OMA AIRPORT 104.23 ▲ 0.21% AMX ADR 26.09 ▼ 0.04% FEMSA ADR 130.35 ▲ 0.26% CEMEX ADR 12.70 ▲ 1.68% PETROBRAS ADR 18.54 ▲ 1.92% VALE ADR 14.25 ▲ 1.06% ITAU ADR 8.40 ▲ 0.96% SANTANDER BR 5.40 ▲ 0.56% AMBEV ADR 3.11 ▲ 0.97% CSN 1.01 ▼ 0.50% GERDAU 4.64 ▼ 0.85% LATAM ADR 51.58 ▼ 0.31% BTC 66,032 ▼ 0.71% ETH 1,931 ▲ 0.14% SOL 77.63 ▼ 0.61% XRP 1.14 ▼ 0.33% BNB 571.09 ▼ 0.44% ADA 0.17 ▲ 0.09% DOGE 0.07 ▼ 0.75% AVAX 6.52 ▼ 0.63% LINK 8.67 ▲ 0.21% DOT 0.84 ▼ 0.57% LTC 46.58 ▼ 0.50% BCH 222.18 ▼ 0.68% TRX 0.33 ▲ 0.19% XLM 0.19 ▼ 1.07% HBAR 0.07 ▲ 2.64% NEAR 1.89 ▼ 2.43% ATOM 1.46 ▼ 1.35% AAVE 96.12 ▲ 0.57% SELIC 14.25% EMBRAER 82.65 ▼ 0.77% EMBRAER ADR 65.47 ▼ 0.70% JBS 11.95 ▼ 0.67% JBS BDR 60.22 ▼ 0.94% MBRF3 15.11 ▲ 4.06% MBRFY 2.95 ▲ 1.37% INTER 5.58 ▼ 0.71% EGX 53,923 ▼ 0.12% USD/ZAR 16.46 ▲ 0.04% USD/NGN 1,376 — 0.00% NIKKEI 66,116 ▼ 0.18% CSI300 4,717 ▼ 0.46% HSI 24,893 ▼ 0.95% NIFTY 23,996 ▼ 0.79% KOSPI 6,798 ▲ 0.74% JCI 6,334 ▼ 0.09% USD/JPY 163.03 ▼ 0.07% USD/CNY 6.7609 ▲ 0.06% DAX 25,147 ▲ 0.54% CAC 8,439 ▲ 0.90% FTSE 10,702 ▲ 1.10% MIB 52,762 ▲ 0.91% IBEX 19,576 ▲ 1.01% STOXX 646.65 ▲ 0.54% EUR/USD 1.1406 ▲ 0.02% GBP/USD 1.3372 ▼ 0.05% SPX 7,509 ▲ 0.89% DJI 52,225 ▲ 0.74% NDX 29,155 ▲ 1.93% RUT 2,987 ▲ 1.53% TSX 35,369 ▲ 1.17% VIX 17.45 ▲ 2.35% USD/CAD 1.4101 ▼ 0.04% US10Y 4.6280 ▲ 0.65%
since 2009
Wednesday, July 22, 2026

Covid-19: Updated count of reported injuries and deaths after vaccines in EU member states (December 4)

By · December 20, 2021 · 5 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – EudraVigilance, the European database where adverse reactions to vaccines are reported, had collected as of December 4; 32,649 reports of deaths and 3,003,296 reports of injuries (half of them serious) from people who received some of the four experimental injections licensed at this time within the member countries of the European Union.

In the previous report, dated November 20, the number of reported deaths was 31,014, and injuries were 2,890,600.

Read also: Check out our coverage on curated alternative narratives

EudraVigilance was launched by the European Medicines Agency in 2012 to provide public access to reports of suspected side effects. These reports are submitted electronically to EudraVigilance by national medicines regulatory authorities and pharmaceutical companies that hold marketing authorizations (licenses) for drugs.

Through December 4, 2021, its report lists 32,649 reports of deaths and 3,003,296 reports of injuries following injections with any of the four experimental vaccines currently approved in the EU.

MODERNA – COVID-19 mRNA VACCINE (CX-024414)
PFIZER-BioNTech – COVID-19 mRNA VACCINE
ASTRAZENECA – COVID-19 VACCINE (CHADOX1 NCOV-19)
JANSSEN – COVID-19 VACCINE (AD26.COV2.S )

Of the total number of registered injuries, almost half (1,409,643) are severe injuries*.

*According to Eudravigilance, “seriousness provides information on the suspected undesirable effect; it can be classified as ‘serious’ if it corresponds to a medical event that results in death, is life-threatening, requires hospitalization, results in another medically important condition, or prolongs existing hospitalization, results in persistent or significant disability or incapacity, or is a congenital anomaly/congenital disability.”

RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →

As we have discussed in previous reports, we have the following information thanks to a subscriber to the Health Impact News website in Europe, who is undertaking the work of expanding on the details in the reports of each of the four COVID-19 injections that we include here. This subscriber volunteered to do this, and it is a lot of work to tabulate each reaction with injuries and deaths, as there is no place in the EudraVigilance system to tabulate all the results.

It should be noted that, just as not all reported deaths and injuries need necessarily be vaccine-related, it is well known that these reports represent a very minimal amount of the actual cases, as most death and injury events are not being reported.

We want to recommend once again reading the analysis ( (in French, please use online translator) made by Laurent Mucchielli, research director of the French National Center for Scientific Research (CNRS), who reviewed several databases of adverse event reports to COVID vaccines worldwide and ended up launching an alert directly to all: “We are facing an unprecedented mortality, and a moratorium must be put on this vaccination”.

Here are the EudraVigilance data summarized up to November 20, 2021.

Total reactions for the Pfizer/BioNTech vaccine:

  • 15,061 deaths and 1,399,513 injuries.
    a 04/12/2021
  • 38,170 Blood and lymphatic disorders, incl. 217 deaths
  • 43,454 Cardiac disorders incl. 2,204 deaths
  • 404 Congenital, familial, and genetic disorders, incl. 38 deaths
  • 18,886 Disorders of the ear and labyrinth, incl. Ten deaths
  • 1,330 Endocrine disorders, incl. 5 deaths
  • 21,574 Eye disorders incl. 35 deaths
  • 115,450 Gastrointestinal disorders incl. 602 deaths
  • 354,635 General disorders and disorders at the site of administration, incl. 4,251 deaths
  • 1,589 Hepatobiliary disorders incl. 78 deaths
  • 15,371 Immune system disorders incl. 77 deaths
  • 57,255 Infections and infestations incl. 1,605 deaths
  • 22,928 Injuries, intoxication, and procedural complications, incl. 261 deaths
  • 34,691 Investigations incl. 464 deaths
  • 9,568 Disorders of metabolism and nutrition incl. 256 deaths
  • 172,420 Musculoskeletal and connective tissue disorders incl. 187 deaths
  • 1,254 Benign malignant, malignant, and unspecified neoplasms (incl. cysts and polyps) incl. 122 deaths236,435 Nervous system disorders, incl. 1,609 deaths
  • 2000 Pregnancy, puerperium, and perinatal conditions incl. 60 deaths215 Product issues incl. 3 deaths
  • 25493 Psychiatric disorders incl. 182 deaths
  • 4,981 Renal and urinary disorders incl. 236 deaths
  • 49,076 Reproductive system and breast disorders, incl. 5 deaths
  • 60,177 Respiratory, thoracic, and mediastinal disorders incl. 1,664 deaths
  • 65,710 Skin and subcutaneous tissue disorders, incl. 128 deaths
  • 3,007 Social circumstances incl. 19 deaths
  • 7,280 Medical and surgical procedures incl. 90 deaths36,160 Vascular disorders incl. 653 deaths

Total reactions to the Moderna vaccine:

  • 9,084 deaths and 409,189 injuries
    a 04/12/2021
  • 8,678 Blood and lymphatic system disorders, incl. 102 deaths
  • 13,650 Cardiac disorders incl. 953 deaths
  • 166 Congenital, familial, and genetic disorders, incl. 7 deaths
  • 4,940 Disorders of the ear and labyrinth, incl. 4 deaths
  • 373 Endocrine disorders incl. 4 deaths
  • 5,992 Eye disorders incl. 31 deaths
  • 33,407 Gastrointestinal disorders incl. 339 deaths
  • 109,178 General disorders and administration site disorders, incl. 3,117 deaths
  • 673 Hepatobiliary disorders incl. 44 deaths4,054 Immune system disorders, incl. 16 deaths
  • 15,636 Infections and infestations incl. 849 deaths
  • 8,535 Injuries, poisonings, and procedural complications, incl. 172 deaths
  • 8,001 Investigations incl. 211 deaths
  • 3,893 Disorders of metabolism and nutrition incl. 220 deaths
  • 49,233 Musculoskeletal and connective tissue disorders, incl. 184 deaths
  • 568 Benign, malignant and unspecified neoplasms (incl. cysts and polyps) incl. 74 deaths
  • 68,948 Nervous system disorders incl. 870 deaths754 Pregnancy, puerperium, and perinatal conditions, incl. 6 deaths82 Product issues incl. 2 deaths
  • 7,472 Psychiatric disorders incl. 149 deaths
  • 2,398 Renal and urinary disorders incl. 174 deaths
  • 8,859 Reproductive system and breast disorders, incl. 7 deaths18,183 Respiratory, thoracic and mediastinal disorders, incl. 975 deaths
  • 21,946 Disorders of the skin and subcutaneous tissue, incl. 82 deaths
  • 1,872 Social circumstances incl. 39 deaths
  • 1,642 Medical and surgical procedures incl. 115 deaths
  • 10,056 Vascular disorders incl. 338 deaths

Total reactions for the Oxford/AstraZeneca vaccine:

  • 6,515 deaths and 1,088,775 injuries.
    a 04/12/2021
  • 13,292 Blood and lymphatic system disorders, incl. 254 deaths
  • 19,523 Cardiac disorders incl. 720 deaths
  • 203 Familial congenital and genetic disorders, incl. 7 deaths
  • 12,845 Disorders of the ear and labyrinth, incl. 4 deaths
  • 619 Endocrine disorders incl. 4 deaths
  • 19,170 Eye disorders incl. 29 deaths
  • 103,368 Gastrointestinal disorders incl. 340 deaths
  • 286,356 General disorders and administration site disorders incl. 1,544 deaths
  • 971 Hepatobiliary disorders incl. 62 deaths
  • 4,99 Immune system disorders incl. 30 deaths
  • 33,416 Infections and infestations incl. 441 deaths
  • 12,583 Injury poisoning and procedural complications incl. 180 deaths
  • 23,958 Investigations incl. 159 deaths
  • 12,472 Disorders of metabolism and nutrition incl. 96 deaths
  • 161,308 Musculoskeletal and connective tissue disorders incl. 114 deaths
    650 Benign, malignant and unspecified neoplasms (incl. cysts and polyps) incl. 25 deaths
  • 223,680 Nervous system disorders incl. 1,007 deaths
  • 533 Pregnancy, puerperium and perinatal conditions, incl. 14 deaths
  • 191 Product issues incl. 1 death
  • 20,150 Psychiatric disorders incl. 60 deaths
  • 4,093 Renal and urinary disorders incl. 63 deaths
  • 15,594 Reproductive system and breast disorders, incl. 2 deaths
  • 38,722 Respiratory, thoracic and mediastinal disorders, incl. 817 deaths
  • 49,877 Skin and subcutaneous tissue disorders, incl. 53 deaths
  • 1,533 Social circumstances incl. 6 deaths
  • 1,499 Medical and surgical procedures, incl. 26 deaths
  • 27,179 Vascular disorders incl. 457 deaths

Total reactions for the Johnson & Johnson vaccine:

  • 1,989 deaths and 105,819 injuries.
    a 04/12/2021
  • 1,029 Blood and lymphatic system disorders, incl. 41 deaths
  • 1,952 Cardiac disorders incl. 169 deaths
  • 36 Congenital, familial, and genetic disorders
  • 1,080 Hearing and labyrinth disorders, incl. 2 deaths
  • 72 Endocrine disorders incl. 1 death
  • 1,415 Eye disorders incl. 7 deaths
  • 8,743 Gastrointestinal disorders incl. 80 deaths
  • 27,925 General disorders and administration site disorders incl. 533 deaths
  • 130 Hepatobiliary disorders incl. 11 deaths
  • 473 Immune system disorders, incl. 9 deaths
  • 4,676 Infections and infestations incl. 157 deaths
  • 974 Injuries, intoxications and procedural complications, incl. 20 deaths
  • 4,927 Investigations incl. 111 deaths
  • 664 Disorders of metabolism and nutrition incl. 50 deaths
  • 15,331 Musculoskeletal and connective tissue disorders incl. 45 deaths
  • 59 Benign, malignant, malignant and unspecified neoplasms (incl. cysts and polyps) incl. 4 deaths
  • 20,725 Nervous system disorders incl. 219 deaths
  • 43 Pregnancy, puerperium, and perinatal conditions, incl. 1 death
  • 32 Problems with the product
  • 1,479 Psychiatric disorders incl. 17 deaths
  • 443 Renal and urinary disorders incl. 26 deaths
  • 2,249 Reproductive system and breast disorders, incl. 6 deaths
  • 3,799 Respiratory, thoracic and mediastinal disorders incl. 259 deaths
  • 3,241 Skin and subcutaneous tissue disorders, incl. 8 deaths
  • 337 Social circumstances incl. 4 deaths
  • 718 Medical and surgical procedures incl. 58 deaths
  • 3267 Vascular disorders incl. 151 deaths

This is public information funded by the European Medicines Agency (EMA), and anyone can use the EudraVigilance system and verify this data.

Join us on Telegram: t.me/theriotimes

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.